These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 21552028)
21. A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies. Liu B; Gao S; Li S Gynecol Obstet Invest; 2017; 82(3):209-222. PubMed ID: 28183074 [TBL] [Abstract][Full Text] [Related]
22. Value of PET-CT in avoiding multimodality therapy in operable cervical cancer. Goyal BK; Singh H; Kapur K; Duggal BS; Jacob MJ Int J Gynecol Cancer; 2010 Aug; 20(6):1041-5. PubMed ID: 20683414 [TBL] [Abstract][Full Text] [Related]
23. Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan staging prior to planned radical hysterectomy and pelvic lymphadenectomy. Unger JB; Ivy JJ; Ramaswamy MR; Charrier A; Connor P Int J Gynecol Cancer; 2005; 15(6):1060-4. PubMed ID: 16343182 [TBL] [Abstract][Full Text] [Related]
26. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784 [TBL] [Abstract][Full Text] [Related]
27. Adenoma malignum of the uterine cervix: ultrasonographic findings in 11 patients. Park SB; Moon MH; Hong SR; Lee MS; Cho HC; Han BH; Lim KT Ultrasound Obstet Gynecol; 2011 Dec; 38(6):716-21. PubMed ID: 21919103 [TBL] [Abstract][Full Text] [Related]
28. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy. Chung HH; Park NH; Kim JW; Song YS; Chung JK; Kang SB Gynecol Obstet Invest; 2009; 67(1):61-6. PubMed ID: 18843187 [TBL] [Abstract][Full Text] [Related]
29. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer. Onal C; Oymak E; Findikcioglu A; Reyhan M Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181 [TBL] [Abstract][Full Text] [Related]
31. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer. Chung HH; Kang KW; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Chung JK; Kang SB Am J Obstet Gynecol; 2010 Aug; 203(2):156.e1-5. PubMed ID: 20435285 [TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma. Perez-Medina T; Pereira A; Mucientes J; García-Espantaleón M; Jiménez JS; Calles L; Rodríguez B; Iglesias E Int J Gynecol Cancer; 2013 Jan; 23(1):170-5. PubMed ID: 23196756 [TBL] [Abstract][Full Text] [Related]
33. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings. Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337 [TBL] [Abstract][Full Text] [Related]
34. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889 [TBL] [Abstract][Full Text] [Related]
35. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Narayan K; McKenzie AF; Hicks RJ; Fisher R; Bernshaw D; Bau S Int J Gynecol Cancer; 2003; 13(5):657-63. PubMed ID: 14675351 [TBL] [Abstract][Full Text] [Related]
36. Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures. Hansen HV; Loft A; Berthelsen AK; Christensen IJ; Høgdall C; Engelholm SA Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1833-9. PubMed ID: 26194714 [TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography-computed tomography has a clinical impact for patients with cervical cancer. Sandvik RM; Jensen PT; Hendel HW; Palle C Dan Med Bull; 2011 Mar; 58(3):A4240. PubMed ID: 21371401 [TBL] [Abstract][Full Text] [Related]
38. Metabolic response of pelvic and para-aortic lymph nodes during radiotherapy for carcinoma of the uterine cervix: using positron emission tomography/computed tomography. Yoon MS; Nam TK; Chung WK; Jeong SY; Ahn SJ; Nah BS; Song JY; Jeong JU Int J Gynecol Cancer; 2011 May; 21(4):699-705. PubMed ID: 21546872 [TBL] [Abstract][Full Text] [Related]
39. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings. Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911 [TBL] [Abstract][Full Text] [Related]
40. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines). Fischerová D; Cibula D Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]